Give me a high-yield summary of reticulocytes required for NEET PG 2026.
reticulocytes structure maturation development erythropoiesis
reticulocyte count normal values reticulocyte index clinical significance anemia
| Parameter | Value |
|---|---|
| Reticulocyte count (absolute) | 50,000 – 100,000 cells/μL |
| Reticulocyte % (adults) | 0.5% – 1.5% |
| Reticulocyte % (neonates) | 2% – 6% (physiologically elevated) |
| Time in bone marrow (reticulocyte stage) | ~1 day |
| Time in peripheral blood (normal) | ~1 day |
| Time in peripheral blood (severe anemia/EPO surge) | up to 2–3 days (shift reticulocytes / stress reticulocytes) |
Pronormoblast → Basophilic normoblast → Polychromatic normoblast → Orthochromatic normoblast (nucleus extruded) → Reticulocyte → Mature RBC
RPI = (Patient Hct / Normal Hct) × Reticulocyte% × (1 / Maturation factor)
| Hematocrit | Maturation factor (days) |
|---|---|
| 45% | 1.0 |
| 35% | 1.5 |
| 25% | 2.0 |
| 15% | 2.5 |
| RPI | Interpretation |
|---|---|
| >2.5 | Adequate marrow response → Hemolysis or blood loss |
| <2 | Inadequate response → Hypoproliferative anemia or Maturation defect |
CRC = Reticulocyte% × (Patient Hct / 45)
Anemia
├── RPI >2.5 (Hyperproliferative) → Hemolytic anemia, Acute blood loss
└── RPI <2 (Hypo/Ineffective)
├── Normal MCV + Normal smear → Hypoproliferative (Iron deficiency early, aplastic anemia, CKD, hypothyroidism)
└── Abnormal MCV / Abnormal smear → Maturation defect
├── Macrocytes → B12/Folate deficiency, MDS
└── Microcytes/Hypochromia → Thalassemia, Sideroblastic anemia
| Condition | Reticulocyte Count |
|---|---|
| Hemolytic anemia | ↑↑ (markedly elevated) |
| Acute post-hemorrhagic anemia | ↑ (peaks at day 7–10) |
| Iron deficiency anemia (untreated) | ↓ or normal |
| Post-iron/B12 treatment | ↑ (reticulocyte crisis: peaks day 7–10) |
| Aplastic anemia | ↓↓ (< 1%, absolute count very low) |
| Anemia of CKD | ↓ (EPO deficiency) |
| Thalassemia major | Low RPI despite erythroid hyperplasia (ineffective erythropoiesis) |
| Megaloblastic anemia | Low RPI (ineffective erythropoiesis) |
ARC = Reticulocyte% × RBC count
Convert this high-yield topic into very high-yield Anki cards, twenty in number. Also, I want it in the import ready format to be imported into AnkiDroid app.
/output/reticulocytes_anki.txt
Format: Tab-separated, AnkiDroid-readyreticulocytes_anki.txt to your Android device (via USB, Google Drive, WhatsApp, etc.)..txt file.NEET PG 2026 > Reticulocytes| # | Front | Back |
|---|---|---|
| 1 | Supravital stains used to identify reticulocytes? | Brilliant cresyl blue & New methylene blue |
| 2 | Residual contents in a reticulocyte? | RNA, ribosomes, mitochondria, remnant ER (no nucleus) |
| 3 | At which stage is the nucleus extruded? | Orthochromatic normoblast |
| 4 | Correct erythropoiesis maturation sequence? | Pronormoblast → Basophilic → Polychromatic → Orthochromatic normoblast → Reticulocyte → RBC |
| 5 | Normal reticulocyte % in adults? | 0.5% – 1.5% |
| 6 | Normal reticulocyte % in neonates? | 2% – 6% |
| 7 | Normal absolute reticulocyte count? | 50,000 – 100,000 cells/µL |
| 8 | Formula for CRC? | CRC = Retic% × (Patient Hct ÷ 45); >2% = adequate response |
| 9 | Formula for RPI? | RPI = (Pt Hct ÷ Normal Hct) × Retic% × (1 ÷ Maturation factor) |
| 10 | RPI >2.5 indicates? | Hyperproliferative — hemolysis or acute blood loss |
| 11 | RPI <2 indicates? | Hypoproliferative OR maturation defect (ineffective erythropoiesis) |
| 12 | Maturation correction factors for RPI? | Hct 45%=1.0 / 35%=1.5 / 25%=2.0 / 15%=2.5 |
| 13 | What are shift/stress reticulocytes? | Prematurely released; circulate 2–3 days; appear as polychromatophilic macrocytes |
| 14 | Reticulocyte finding in aplastic anemia? | Markedly absent / very low (<25,000/µL) |
| 15 | Reticulocyte count after iron/B12 therapy? | Reticulocyte crisis — rises day 3–5, peaks day 7–10 |
| 16 | Low retic despite erythroid hyperplasia = ? | Ineffective erythropoiesis (thalassemia major, megaloblastic anemia) |
| 17 | CHr / Ret-He significance? | CHr <28 pg = functional iron deficiency; earliest marker, useful in CKD on EPO |
| 18 | Reticulocytes on routine smear (no supravital stain)? | Polychromatophilic macrocytes |
| 19 | Anemia with the highest reticulocyte count? | Hemolytic anemia (especially AIHA) |
| 20 | Earliest lab indicator of treatment response in anemia? | Reticulocyte rise — day 3–5, peaks day 7–10 |
The link you have given is not working, the file link. I want you to put it in a format so that I can copy and paste.
.txt file on your phone (using any text editor), then import into AnkiDroid.#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Reticulocytes
What supravital stains are used to identify reticulocytes? Brilliant cresyl blue and New methylene blue — precipitate residual RNA into a blue reticular network
What residual contents are present in a reticulocyte? Residual RNA, ribosomes, mitochondria, and remnant endoplasmic reticulum (no nucleus)
At which stage of erythroid maturation is the nucleus extruded? Orthochromatic normoblast stage → gives rise to the reticulocyte
What is the correct maturation sequence of erythropoiesis? Pronormoblast → Basophilic normoblast → Polychromatic normoblast → Orthochromatic normoblast → Reticulocyte → Mature RBC
What is the normal reticulocyte percentage in adults? 0.5% – 1.5%
What is the normal reticulocyte percentage in neonates? 2% – 6% (physiologically elevated)
What is the normal absolute reticulocyte count? 50,000 – 100,000 cells/µL (some sources: 25,000 – 75,000/µL)
What is the formula for Corrected Reticulocyte Count (CRC)? CRC = Reticulocyte% × (Patient Hct ÷ 45). CRC >2% = adequate erythropoietic response
What is the formula for Reticulocyte Production Index (RPI)? RPI = (Patient Hct ÷ Normal Hct) × Reticulocyte% × (1 ÷ Maturation factor)
What does RPI >2.5 indicate? Hyperproliferative marrow response → Hemolytic anemia or Acute blood loss
What does RPI <2 indicate? Inadequate marrow response → Hypoproliferative anemia OR Maturation defect (ineffective erythropoiesis)
What are the maturation correction factors used in RPI calculation? Hct 45% = 1.0 | Hct 35% = 1.5 | Hct 25% = 2.0 | Hct 15% = 2.5
What are shift (stress) reticulocytes and when do they appear? Prematurely released reticulocytes in severe anemia/high EPO states; spend 2–3 days in blood instead of 1 day; appear as polychromatophilic macrocytes on smear
What is the hallmark reticulocyte finding in aplastic anemia? Markedly decreased / absent reticulocytes (absolute count very low, <25,000/µL) despite anemia
What happens to the reticulocyte count after starting iron or B12 therapy? Reticulocyte crisis — count rises from day 3–5, peaks at day 7–10 post-treatment
In which condition is the reticulocyte count low despite marked erythroid hyperplasia in the marrow? Ineffective erythropoiesis — e.g., Thalassemia major, Megaloblastic anemia
What is Reticulocyte Hemoglobin Content (CHr / Ret-He) and its significance? Measures functional iron available for erythropoiesis in real time. CHr <28 pg = functional iron deficiency (earliest indicator, useful in CKD on EPO therapy)
How do reticulocytes appear on a routine peripheral blood smear (without supravital stain)? As polychromatophilic macrocytes (larger cells with a bluish tinge due to residual RNA)
Which anemia shows the highest reticulocyte count? Hemolytic anemia (especially autoimmune hemolytic anemia — AIHA)
What is the earliest laboratory indicator of response to specific anemia treatment? Rise in reticulocyte count — begins day 3–5, peaks day 7–10 after starting iron, B12, or folate therapy
# header lines).reticulocytes_anki.txt.Crc?
CRC = Reticulocyte% × (Patient Hct ÷ 45)
| CRC | Meaning |
|---|---|
| >2% | Adequate marrow response (hemolysis / blood loss) |
| <2% | Inadequate response (hypoproliferative or maturation defect) |
Why the big difference
| Hct | Maturation Factor |
|---|---|
| 45% | 1.0 |
| 35% | 1.5 |
| 25% | 2.0 |
| 15% | 2.5 |
| Hct | Maturation Factor |
|---|---|
| ≥ 35% | 1.0 |
| 35% > Hct ≥ 25% | 1.5 |
| 25% > Hct ≥ 20% | 2.0 |
| < 20% | 2.5 |
If Hct is given and it's ≥ 35% — maturation factor = 1, so RPI = CRC. The two values diverge only when Hct drops below 35%.
So make an anki for this one only
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Reticulocytes
What is the maturation factor when Hct ≥ 35%? 1.0
What is the maturation factor when 35% > Hct ≥ 25%? 1.5
What is the maturation factor when 25% > Hct ≥ 20%? 2.0
What is the maturation factor when Hct < 20%? 2.5
What is the formula for Reticulocyte Production Index (RPI)? RPI = CRC ÷ Maturation factor. Where CRC = Reticulocyte% × (Patient Hct ÷ 45)
When does RPI equal CRC (no maturation correction needed)? When Hct ≥ 35% — maturation factor = 1.0, so RPI = CRC
Why is a maturation factor applied in RPI calculation? To correct for prematurely released (shift) reticulocytes that spend longer in blood — they falsely inflate the reticulocyte count
.txt file → AnkiDroid ≡ → Import.Just one card
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Reticulocytes
What are the maturation correction factors used in RPI calculation? Hct ≥ 35% = 1.0 | 35% > Hct ≥ 25% = 1.5 | 25% > Hct ≥ 20% = 2.0 | Hct < 20% = 2.5
Also give the summary of reticulocytosis, I mean the reticulocytes, in one Anki card. The front portion should be reticulocytes, the back portion is the entire summary.
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Reticulocytes
Reticulocytes — Complete Summary DEFINITION: Immature anucleate RBCs with residual RNA, ribosomes, mitochondria. Identified by supravital stain (Brilliant cresyl blue / New methylene blue) as blue reticular network. Appear as polychromatophilic macrocytes on routine smear.
MATURATION SEQUENCE: Pronormoblast → Basophilic normoblast → Polychromatic normoblast → Orthochromatic normoblast (nucleus extruded here) → Reticulocyte → Mature RBC
NORMAL VALUES: Adults: 0.5–1.5% | Neonates: 2–6% | Absolute count: 50,000–100,000/µL | Time in blood: 1 day (normal), 2–3 days (stress/shift)
CRC (Corrected Reticulocyte Count): CRC = Retic% x (Patient Hct / 45). CRC >2% = adequate response
RPI (Reticulocyte Production Index): RPI = CRC / Maturation factor. RPI >2.5 = Hemolysis/Blood loss. RPI <2 = Hypoproliferative OR Ineffective erythropoiesis
MATURATION FACTORS: Hct ≥35% = 1.0 | 35%>Hct≥25% = 1.5 | 25%>Hct≥20% = 2.0 | Hct <20% = 2.5
SHIFT RETICULOCYTES: Prematurely released in severe anemia/high EPO; circulate 2–3 days; seen as polychromatophilic macrocytes
CLINICAL CORRELATES: Hemolytic anemia = highest retic count | Aplastic anemia = absent reticulocytes | Post iron/B12 therapy = reticulocyte crisis, peaks day 7–10 | Thalassemia major + Megaloblastic anemia = low RPI despite erythroid hyperplasia (ineffective erythropoiesis) | CKD = low retic (EPO deficiency)
CHr/Ret-He: <28 pg = functional iron deficiency; earliest marker; useful in CKD on EPO therapy
Recheck the format. When I put it, the front is showing everything except the definition. The definition is coming in the back part.
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Reticulocytes
Reticulocytes — Complete Summary DEFINITION: Immature anucleate RBCs with residual RNA, ribosomes, mitochondria. Identified by supravital stain (Brilliant cresyl blue / New methylene blue). Appear as polychromatophilic macrocytes on routine smear. | MATURATION SEQUENCE: Pronormoblast → Basophilic normoblast → Polychromatic normoblast → Orthochromatic normoblast (nucleus extruded) → Reticulocyte → Mature RBC | NORMAL VALUES: Adults: 0.5–1.5% | Neonates: 2–6% | Absolute: 50,000–100,000/µL | Blood time: 1 day (normal), 2–3 days (stress) | CRC: Retic% × (Patient Hct ÷ 45). CRC >2% = adequate response | RPI: CRC ÷ Maturation factor. RPI >2.5 = Hemolysis/Blood loss. RPI <2 = Hypoproliferative OR Ineffective erythropoiesis | MATURATION FACTORS: Hct ≥35% = 1.0 | 35%>Hct≥25% = 1.5 | 25%>Hct≥20% = 2.0 | Hct <20% = 2.5 | SHIFT RETICULOCYTES: Prematurely released in severe anemia/high EPO; circulate 2–3 days; polychromatophilic macrocytes on smear | CLINICAL CORRELATES: Hemolytic anemia = highest retic count. Aplastic anemia = absent reticulocytes. Post iron/B12 = reticulocyte crisis peaks day 7–10. Thalassemia major + Megaloblastic = low RPI despite erythroid hyperplasia (ineffective erythropoiesis). CKD = low retic (EPO deficiency) | CHr/Ret-He: <28 pg = functional iron deficiency; earliest marker; useful in CKD on EPO
Give me very high yield 20 anki cards on the topic autoimmune hemolytic anemia. Only include the pathology aspects in an import ready form.
autoimmune hemolytic anemia pathology classification warm cold antibody mechanism
autoimmune hemolytic anemia DAT Coombs test spherocytes peripheral smear findings
warm AIHA IgG extravascular hemolysis spleen pathophysiology causes
cold agglutinin disease IgM intravascular hemolysis paroxysmal cold hemoglobinuria Donath Landsteiner
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::AIHA
What are the two main types of AIHA based on thermal amplitude of antibody? Warm AIHA (antibody active at 37°C) and Cold AIHA (antibody active at <37°C, optimally 4°C)
What is the antibody type in Warm AIHA? IgG (occasionally IgG + complement)
What is the antibody type in Cold Agglutinin Disease? IgM (fixes complement efficiently)
What is the antibody type in Paroxysmal Cold Hemoglobinuria (PCH)? IgG — the Donath-Landsteiner antibody (biphasic: binds RBCs in cold, lyses them at 37°C)
What antigen does the Donath-Landsteiner antibody target? P antigen on RBCs
What is the mechanism of hemolysis in Warm AIHA? Extravascular hemolysis — IgG-coated RBCs phagocytosed by splenic macrophages (Fc receptor-mediated)
What is the mechanism of hemolysis in Cold Agglutinin Disease? IgM fixes complement (C3b) on RBCs → extravascular hemolysis in liver (Kupffer cells) + some intravascular hemolysis
What is the mechanism of hemolysis in PCH? Intravascular hemolysis — IgG binds RBCs in cold periphery, then complement cascade is activated at core temperature (37°C) → lysis
What is the classic peripheral smear finding in Warm AIHA? Spherocytes (loss of RBC membrane during partial phagocytosis by splenic macrophages)
What does the Direct Antiglobulin Test (DAT / Direct Coombs Test) detect? Antibodies (IgG) and/or complement (C3d) already bound to the patient's RBCs in vivo
What does the Indirect Antiglobulin Test (IAT / Indirect Coombs Test) detect? Free antibodies in the patient's serum that can bind to test RBCs in vitro
DAT result pattern in Warm AIHA? IgG positive (with or without C3d)
DAT result pattern in Cold Agglutinin Disease? C3d positive only (IgM elutes off RBCs at 37°C during testing, leaving only complement)
DAT result pattern in PCH? C3d positive (IgG elutes off; complement remains)
What are the primary/secondary causes of Warm AIHA? Primary (idiopathic) 50%. Secondary: SLE (most common autoimmune cause), CLL (most common malignancy), lymphomas, drugs (methyldopa, penicillin)
What are the causes of Cold Agglutinin Disease? Primary (idiopathic, elderly). Secondary: Mycoplasma pneumoniae (anti-I antibody), Infectious mononucleosis/EBV (anti-i antibody), lymphoproliferative disorders
What are the causes of PCH? Classically syphilis (tertiary). Now most common cause: viral infections in children (post-viral). Also congenital syphilis.
What is the cold agglutinin specificity in Mycoplasma pneumoniae vs EBV infection? Mycoplasma pneumoniae → anti-I antibody | EBV (infectious mononucleosis) → anti-i antibody
What is the pathological basis of spherocyte formation in AIHA? Splenic macrophages partially phagocytose IgG-coated RBC membrane → RBC loses surface area but retains volume → becomes spherical → less deformable → trapped and destroyed in spleen
What is DAT-negative AIHA and when is it seen? AIHA with negative DAT (~5–10% of cases) — occurs when antibody levels are below detection threshold or antibody is IgA/IgM class (not detected by standard anti-IgG reagent). Diagnose with more sensitive techniques.
.txt file → AnkiDroid ≡ → Import → confirm Tab separator.Will the above format help me to answer NEET PG 2026 questions when asked from pathology aspect?
| Missing Topic | Why It Matters |
|---|---|
| Microangiopathic hemolytic anemia (MAHA) vs AIHA | Frequent differentiator MCQ — schistocytes vs spherocytes |
| Rouleaux formation vs agglutination on smear | Cold AIHA smear finding — commonly asked |
| Complement pathway (classical vs alternative) in hemolysis | Pathology depth question |
| Hemosiderinuria / hemoglobinuria in intravascular hemolysis | PCH and cold AIHA specific |
| Haptoglobin, LDH, unconjugated bilirubin changes in hemolysis | Lab marker MCQs |
| Spleen vs liver as site of destruction | Warm = spleen, Cold = liver — asked directly |
| Osmotic fragility in spherocytosis | Increased in AIHA spherocytes — confused with hereditary spherocytosis |
| AIHA vs Hereditary Spherocytosis distinction | Both have spherocytes — DAT positive vs negative is the key |
| Drug-induced immune hemolysis mechanisms | Hapten (penicillin), immune complex (quinidine), autoantibody (methyldopa) |
Yes, but limit total cards to just twenty. Be smart.
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::AIHA
What are the two types of AIHA based on thermal amplitude, their antibody class, and site of hemolysis? Warm AIHA: IgG, active at 37°C, extravascular hemolysis in SPLEEN | Cold Agglutinin Disease: IgM, active at <37°C, extravascular hemolysis in LIVER (Kupffer cells) + some intravascular | PCH: biphasic IgG (Donath-Landsteiner), intravascular hemolysis
What is the DAT pattern in Warm AIHA, Cold Agglutinin Disease, and PCH? Warm AIHA: IgG positive ± C3d | Cold Agglutinin Disease: C3d only (IgM elutes off at 37°C during testing) | PCH: C3d only (IgG elutes off)
What is the Donath-Landsteiner antibody — class, target antigen, and mechanism? Biphasic IgG antibody targeting P antigen. Binds RBCs in cold periphery → complement activated at 37°C → intravascular hemolysis. Seen in PCH.
What are the causes of Warm AIHA? Idiopathic (50%). Secondary: SLE (most common autoimmune), CLL (most common malignancy), lymphomas, drugs (methyldopa, penicillin)
What are the causes of Cold Agglutinin Disease? Mycoplasma pneumoniae (anti-I), EBV/infectious mononucleosis (anti-i), lymphoproliferative disorders, idiopathic (elderly)
What are the causes of PCH? Previously: tertiary syphilis. Now most common: post-viral infections in CHILDREN (most common cause of hemolysis in children after viral illness)
What is the pathological basis of spherocyte formation in AIHA? IgG-coated RBCs partially phagocytosed by splenic macrophages → RBC loses membrane but retains volume → spherical shape → reduced deformability → trapped and destroyed in spleen
How do you distinguish AIHA spherocytes from Hereditary Spherocytosis (HS) spherocytes? Both: spherocytes on smear + increased osmotic fragility. KEY DIFFERENCE: DAT positive in AIHA | DAT negative in HS. HS also has family history and splenomegaly from birth.
What are the peripheral smear findings in Warm AIHA vs Cold Agglutinin Disease? Warm AIHA: spherocytes | Cold Agglutinin Disease: RBC agglutination (clumping) on smear — disappears on warming. Both differ from MAHA which shows schistocytes.
How do you distinguish AIHA from MAHA (Microangiopathic Hemolytic Anemia) on smear? AIHA: spherocytes, DAT positive | MAHA (TTP, HUS, DIC): schistocytes (fragmented RBCs), DAT negative
What are the lab findings of intravascular hemolysis? ↓ Haptoglobin (earliest, most sensitive), ↑ LDH, ↑ unconjugated bilirubin, hemoglobinemia, hemoglobinuria (pink/red urine), hemosiderinuria (late — iron in urine after days)
What are the lab findings of extravascular hemolysis? ↓ Haptoglobin, ↑ LDH, ↑ unconjugated bilirubin, NO hemoglobinuria, NO hemoglobinemia. Splenomegaly present.
What are the three mechanisms of drug-induced immune hemolytic anemia with examples? 1. Hapten mechanism: drug coats RBC → IgG antibody → extravascular hemolysis (Penicillin) | 2. Immune complex (innocent bystander): drug-antibody complexes activate complement on RBC → intravascular hemolysis (Quinidine, Cephalosporins) | 3. Autoantibody induction: drug induces true autoantibody against RBC antigen (Methyldopa — anti-Rh antibody)
What is the complement pathway activated in Cold Agglutinin Disease and what fragment coats RBCs? Classical complement pathway activated by IgM → C3b coats RBCs → phagocytosis by liver Kupffer cells via CR1 (complement receptor). C3d remains on RBC surface (detected by DAT).
What is DAT-negative AIHA? AIHA with negative standard DAT (~5–10%). Occurs when: antibody levels below detection threshold, or antibody is IgA/IgM class (not detected by standard anti-IgG reagent). Diagnose with high-sensitivity flow cytometry or gel-based techniques.
What is the osmotic fragility in AIHA and why? INCREASED osmotic fragility — spherocytes have reduced surface area-to-volume ratio, less able to expand in hypotonic solution → lyse earlier than normal biconcave RBCs
What is the M:E ratio in bone marrow in AIHA and what does it indicate? M:E ratio <1:1 (erythroid hyperplasia) — compensatory response to peripheral hemolysis. Indicates hyperproliferative marrow. RPI >2.5.
What RBC morphology is seen in rouleaux formation vs cold agglutination, and how to differentiate? Rouleaux: RBCs stacked like coins — seen in multiple myeloma, high fibrinogen. Cold agglutination: irregular grape-like RBC clumps — seen in Cold Agglutinin Disease. Agglutination DISAPPEARS on warming the slide; rouleaux does not.
What is the antiglobulin (Coombs) reagent and what does it contain? Antihuman globulin (AHG) — contains anti-IgG and anti-C3d antibodies. Used in both DAT (detects in vivo coating) and IAT (detects serum antibodies in vitro).
What are the secondary causes of AIHA grouped by category? Autoimmune: SLE, RA | Malignancy: CLL, lymphomas, ovarian teratoma | Infections: Mycoplasma (cold), EBV (cold), syphilis (PCH) | Drugs: methyldopa, penicillin, quinidine | Immunodeficiency: CVID
This is good, but I need a better format so that I can easily copy, paste, and import.
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::AIHA
What are the two types of AIHA based on thermal amplitude, their antibody class, and site of hemolysis? Warm AIHA: IgG, active at 37°C, extravascular hemolysis in SPLEEN | Cold Agglutinin Disease: IgM, active at <37°C, extravascular hemolysis in LIVER (Kupffer cells) + some intravascular | PCH: biphasic IgG (Donath-Landsteiner), intravascular hemolysis
What is the DAT pattern in Warm AIHA, Cold Agglutinin Disease, and PCH? Warm AIHA: IgG positive ± C3d | Cold Agglutinin Disease: C3d only (IgM elutes off at 37°C during testing) | PCH: C3d only (IgG elutes off)
What is the Donath-Landsteiner antibody — class, target antigen, and mechanism? Biphasic IgG antibody targeting P antigen. Binds RBCs in cold periphery → complement activated at 37°C → intravascular hemolysis. Seen in PCH.
What are the causes of Warm AIHA? Idiopathic (50%). Secondary: SLE (most common autoimmune), CLL (most common malignancy), lymphomas, drugs (methyldopa, penicillin)
What are the causes of Cold Agglutinin Disease? Mycoplasma pneumoniae (anti-I), EBV/infectious mononucleosis (anti-i), lymphoproliferative disorders, idiopathic (elderly)
What are the causes of PCH? Previously: tertiary syphilis. Now most common: post-viral infections in CHILDREN (most common cause of hemolysis in children after viral illness)
What is the pathological basis of spherocyte formation in AIHA? IgG-coated RBCs partially phagocytosed by splenic macrophages → RBC loses membrane but retains volume → spherical shape → reduced deformability → trapped and destroyed in spleen
How do you distinguish AIHA spherocytes from Hereditary Spherocytosis (HS) spherocytes? Both: spherocytes on smear + increased osmotic fragility. KEY DIFFERENCE: DAT positive in AIHA | DAT negative in HS. HS also has family history and splenomegaly from birth.
What are the peripheral smear findings in Warm AIHA vs Cold Agglutinin Disease? Warm AIHA: spherocytes | Cold Agglutinin Disease: RBC agglutination (clumping) on smear — disappears on warming. Both differ from MAHA which shows schistocytes.
How do you distinguish AIHA from MAHA on smear? AIHA: spherocytes, DAT positive | MAHA (TTP, HUS, DIC): schistocytes (fragmented RBCs), DAT negative
What are the lab findings of intravascular hemolysis? ↓ Haptoglobin (earliest, most sensitive), ↑ LDH, ↑ unconjugated bilirubin, hemoglobinemia, hemoglobinuria (pink/red urine), hemosiderinuria (late — iron in urine after days)
What are the lab findings of extravascular hemolysis? ↓ Haptoglobin, ↑ LDH, ↑ unconjugated bilirubin, NO hemoglobinuria, NO hemoglobinemia. Splenomegaly present.
What are the three mechanisms of drug-induced immune hemolytic anemia with examples? 1. Hapten mechanism: drug coats RBC → IgG antibody → extravascular hemolysis (Penicillin) | 2. Immune complex (innocent bystander): drug-antibody complexes activate complement on RBC → intravascular hemolysis (Quinidine, Cephalosporins) | 3. Autoantibody induction: drug induces true autoantibody against RBC antigen (Methyldopa — anti-Rh antibody)
What is the complement pathway activated in Cold Agglutinin Disease and what fragment coats RBCs? Classical complement pathway activated by IgM → C3b coats RBCs → phagocytosis by liver Kupffer cells via CR1 (complement receptor). C3d remains on RBC surface (detected by DAT).
What is DAT-negative AIHA? AIHA with negative standard DAT (~5–10%). Occurs when: antibody levels below detection threshold, or antibody is IgA/IgM class (not detected by standard anti-IgG reagent). Diagnose with high-sensitivity flow cytometry or gel-based techniques.
What is the osmotic fragility in AIHA and why? INCREASED osmotic fragility — spherocytes have reduced surface area-to-volume ratio, less able to expand in hypotonic solution → lyse earlier than normal biconcave RBCs
What is the M:E ratio in bone marrow in AIHA and what does it indicate? M:E ratio <1:1 (erythroid hyperplasia) — compensatory response to peripheral hemolysis. Indicates hyperproliferative marrow. RPI >2.5.
What is the difference between rouleaux formation and cold agglutination on peripheral smear? Rouleaux: RBCs stacked like coins — seen in multiple myeloma, high fibrinogen. Cold agglutination: irregular grape-like RBC clumps — seen in Cold Agglutinin Disease. Agglutination DISAPPEARS on warming the slide; rouleaux does not.
What is the antiglobulin (Coombs) reagent and what does it contain? Antihuman globulin (AHG) — contains anti-IgG and anti-C3d antibodies. Used in both DAT (detects in vivo coating) and IAT (detects serum antibodies in vitro).
What are the secondary causes of AIHA grouped by category? Autoimmune: SLE, RA | Malignancy: CLL, lymphomas, ovarian teratoma | Infections: Mycoplasma (cold), EBV (cold), syphilis (PCH) | Drugs: methyldopa, penicillin, quinidine | Immunodeficiency: CVID
AIHA_anki.txtDo the same with Paroxysmal Nocturnal Hemoglobinuria. Pathology aspect, very high yield 20 anki cards, capable of covering almost 90% or close to 100% of NEET PG 2026 topic.
paroxysmal nocturnal hemoglobinuria PNH pathology PIG-A mutation GPI anchor CD55 CD59
PNH complement hemolysis thrombosis aplastic anemia flow cytometry diagnosis Ham test
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::PNH
What is the fundamental molecular defect in PNH? Somatic mutation in PIGA gene (X-linked, on Xp22.1) in a hematopoietic stem cell → deficient biosynthesis of GPI (glycosylphosphatidylinositol) anchor → loss of all GPI-anchored proteins from cell surface
What is a GPI anchor and why is it important? GPI anchor is a lipid structure that attaches certain protective proteins to the outer cell membrane. In PNH, its absence means complement-regulatory proteins (CD55, CD59) are missing → RBCs unprotected against complement attack
What are CD55 and CD59 — their full names and specific functions? CD55 = Decay Accelerating Factor (DAF) — accelerates decay of C3 and C5 convertases (blocks amplification of complement). CD59 = Membrane Inhibitor of Reactive Lysis (MIRL) / Protectin — blocks formation of Membrane Attack Complex (MAC, C5b-9)
Which complement regulatory protein deficiency is MORE important in PNH hemolysis and why? CD59 deficiency is more critical — it directly prevents MAC (C5b-9) formation. CD55 deficiency amplifies complement activation but CD59 is the last line of defense against lysis
What type of hemolysis occurs in PNH and via which complement pathway? Primarily intravascular hemolysis. Alternative complement pathway is constitutively active at low level — without CD55/CD59, RBCs are lysed by MAC. Acidic conditions (sleep, infection, surgery) accelerate alternative pathway activation.
Why does hemolysis classically worsen at night in PNH? During sleep, mild respiratory acidosis → ↓ pH → activates alternative complement pathway → increased hemolysis → hemoglobinuria in first morning urine (dark urine on waking). Note: this is seen in only ~25% of patients.
What are the three major clinical manifestations / complications of PNH? 1. Intravascular hemolysis (hemoglobinuria, anemia) 2. Thrombosis (most common cause of death) 3. Cytopenias / bone marrow failure (PNH-aplastic anemia syndrome)
Why does thrombosis occur in PNH and what are the common sites? CD59 deficiency on platelets → complement-mediated platelet activation → hypercoagulable state. Also: free hemoglobin scavenges NO → vasoconstriction + platelet aggregation. Sites: hepatic vein (Budd-Chiari syndrome — most characteristic), portal vein, cerebral veins, mesenteric veins
What is the classic abdominal manifestation of PNH thrombosis? Budd-Chiari syndrome (hepatic vein thrombosis) — most characteristic thrombotic complication of PNH. Presents with hepatomegaly, ascites, abdominal pain.
What is the relationship between PNH and Aplastic Anemia (AA)? PNH clone arises in setting of immune-mediated bone marrow destruction (AA). In AA, autoreactive T cells destroy normal HSCs but spare PIGA-mutant (GPI-negative) clones → PNH clone expands. PNH and AA can coexist or transform into each other (PNH-AA syndrome).
What is the peripheral smear finding in PNH? Normocytic normochromic anemia (intravascular hemolysis). No spherocytes (complement-mediated lysis — not partial phagocytosis). Polychromatophilia (reticulocytosis). Pancytopenia may be present if AA component dominates.
What is the Ham test (acidified serum test) — principle and significance? Patient RBCs incubated in acidified normal serum (pH 6.2) → activates alternative complement pathway → PNH RBCs lyse (GPI-negative, no CD55/CD59). Positive in PNH. Now replaced by flow cytometry but still asked in MCQs.
What is the Sucrose Hemolysis Test (Sugar Water Test) — principle? Patient RBCs in isotonic sucrose solution → low ionic strength activates complement → PNH RBCs lyse. More sensitive but LESS specific than Ham test. Used as screening test. Gold standard = flow cytometry.
What is the gold standard diagnostic test for PNH today? Flow cytometry — detects absence of GPI-anchored proteins (CD55, CD59) on RBCs and granulocytes. Shows bimodal distribution of cells. Diagnosis requires ≥5% GPI-negative population. More sensitive and specific than Ham or sucrose tests. (Harrison's, p. 3024)
What is FLAER and why is it preferred in PNH diagnosis? FLAER (Fluorescent Aerolysin) — binds directly to GPI anchor on WBCs/granulocytes. More sensitive than CD55/CD59 testing on RBCs (transfusions can dilute GPI-negative RBCs but not granulocytes). Preferred for minimal residual disease monitoring.
What are the lab findings in PNH? ↓ Haptoglobin, ↑ LDH (markedly), ↑ unconjugated bilirubin, hemoglobinuria, hemosiderinuria, ↓ serum iron (lost in urine), reticulocytosis, pancytopenia (if AA component), DAT NEGATIVE (complement-mediated, not antibody-mediated)
Why is DAT negative in PNH despite complement-mediated hemolysis? Standard DAT detects IgG and C3d on RBCs. In PNH, hemolysis is via MAC (C5b-9) — complement is fully activated to lysis rather than leaving C3d on RBC surface. No antibody is involved → DAT negative. This distinguishes PNH from AIHA.
What is the PIGA gene — location, inheritance pattern, and why one mutation is sufficient? PIGA is on X chromosome (Xp22.1). Males have one X copy, females have one active X (lyonization) → single somatic mutation in one HSC is sufficient to cause GPI deficiency in all its progeny. Germline PIGA mutations are lethal; only somatic mutations cause PNH.
What are the complications of chronic hemoglobinuria / hemosiderinuria in PNH? Chronic iron deficiency (iron lost in urine as hemosiderin) → worsens anemia despite active hemolysis. Also: NO scavenging by free hemoglobin → smooth muscle dystonias (esophageal spasm, erectile dysfunction, abdominal pain)
What is Eculizumab — mechanism, use in PNH, and key fact? Eculizumab = monoclonal antibody against complement protein C5 → blocks cleavage of C5 → prevents MAC (C5b-9) formation → stops intravascular hemolysis. Treatment of choice for PNH. Requires Neisseria meningitidis vaccination before use (C5 blockade increases susceptibility to encapsulated bacteria).
PNH_anki.txtGive the same for sickle cell anemia pathology
sickle cell anemia pathology molecular defect HbS polymerization deoxygenation
sickle cell anemia vaso-occlusion hemolysis organ damage complications pathophysiology
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Sickle Cell Anemia
What is the molecular defect in sickle cell anemia? Single point mutation in the beta-globin gene (chromosome 11) — GAG→GTG codon 6 → Glutamic acid replaced by Valine at position 6 of beta-globin chain → HbS (α2β2S)
What is the genetic inheritance of sickle cell anemia and trait? Autosomal recessive. Sickle cell anemia: homozygous (HbSS). Sickle cell trait: heterozygous (HbAS) — carrier, usually asymptomatic. HbAS provides partial protection against Plasmodium falciparum malaria.
What is the molecular basis of HbS polymerization? Valine at β6 is hydrophobic → fits into a complementary hydrophobic pocket on adjacent deoxyHbS molecule → forms long polymer chains (fibers) → distorts RBC into sickle shape. Polymerization occurs ONLY in the DEOXYGENATED state. Rate depends on the 30th POWER of Hb concentration.
What factors promote HbS polymerization (sickling)? Deoxygenation (low pO2), acidosis (↓ pH), dehydration (↑ MCHC), hyperthermia, infection, stasis, high altitude. All reduce oxygen saturation or increase Hb concentration → promote sickling.
What factors INHIBIT HbS polymerization? HbF (fetal hemoglobin) — does NOT participate in polymer formation → dilutes HbS → inhibits sickling. HbA also inhibits. This is the basis of hydroxyurea therapy (↑ HbF production).
What are irreversibly sickled cells (ISCs) and their significance? After repeated cycles of sickling-unsickling, RBC membrane is permanently damaged → remains sickle-shaped even when re-oxygenated. ISCs are rigid, dehydrated, and have shortened survival. Seen on peripheral smear even in oxygenated state.
What are the two major pathophysiological limbs of sickle cell disease? 1. Vaso-occlusion — sickle cells + endothelial adhesion + inflammation → microvascular occlusion → ischemia/infarction. 2. Intravascular hemolysis — free hemoglobin → scavenges NO → vasoconstriction + platelet activation → pulmonary hypertension, priapism, leg ulcers, stroke.
What is the peripheral smear in sickle cell anemia? Sickle cells (drepanocytes), target cells (codocytes), Howell-Jolly bodies (hyposplenism), nucleated RBCs, polychromatophilia (reticulocytosis), anisocytosis, poikilocytosis. NO spherocytes.
What is the hemoglobin electrophoresis pattern in HbSS, HbAS, and HbSC? HbSS: HbS 80–95%, HbF 5–20%, NO HbA | HbAS (trait): HbA ~60%, HbS ~40% | HbSC disease: HbS ~50%, HbC ~50%, NO HbA. HbF is always present in small amounts.
What is autosplenectomy — mechanism and consequences? Repeated splenic infarctions due to vaso-occlusion → fibrosis → functional asplenia by age 5 years. Consequences: susceptibility to encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis). Howell-Jolly bodies on smear (nuclear remnants not removed by absent spleen).
What is the most common cause of death in children with sickle cell anemia? Infection with encapsulated organisms — especially Streptococcus pneumoniae (pneumococcal sepsis) — due to functional asplenia. Prevention: prophylactic penicillin + pneumococcal vaccine from age 2 months.
What are the vaso-occlusion mediated complications of sickle cell anemia? Painful vaso-occlusive crisis (most common complication), acute chest syndrome, stroke/CNS infarction, avascular necrosis (femoral head most common), dactylitis (hand-foot syndrome — earliest manifestation in infants), renal papillary necrosis, priapism, retinopathy.
What is Acute Chest Syndrome (ACS) in sickle cell disease? New pulmonary infiltrate + fever + chest pain + hypoxia. Caused by vaso-occlusion in pulmonary vasculature ± fat embolism from infarcted bone marrow ± infection. Most common cause of death in adults. Treated with exchange transfusion + antibiotics.
What is dactylitis and why is it the earliest manifestation of sickle cell disease? Dactylitis (hand-foot syndrome) = painful swelling of hands and feet in infants 6 months–2 years. Earliest clinical manifestation. Occurs because small bones of hands/feet are first to undergo vaso-occlusive infarction. Seen after HbF declines and HbS rises.
What is the pathology of sickle cell nephropathy? Renal medulla is hypoxic, hypertonic, and acidic → ideal conditions for sickling → vaso-occlusion → renal papillary necrosis (hematuria, impaired concentrating ability — earliest renal finding), chronic renal failure. Also: microhematuria in sickle cell trait.
What is the bone marrow pathology in sickle cell anemia? Erythroid hyperplasia (compensatory) → M:E ratio <1:1 → expansion of medullary spaces → crew-cut appearance on skull X-ray, hair-on-end pattern (also seen in thalassemia). Bone marrow infarction can cause fat embolism → ACS.
What is the role of NO (nitric oxide) in sickle cell pathophysiology? Free hemoglobin released during intravascular hemolysis scavenges NO → NO deficiency → smooth muscle dysfunction → vasoconstriction, pulmonary hypertension, priapism, leg ulcers, esophageal spasm. This is the hemolysis limb of disease.
What is the mechanism of action of hydroxyurea in sickle cell anemia? Hydroxyurea → inhibits ribonucleotide reductase → increases HbF synthesis (mechanism not fully understood, likely involves stress erythropoiesis) → HbF inhibits HbS polymerization → ↓ sickling, ↓ vaso-occlusive crises, ↓ ACS frequency. Also ↓ WBC and platelet adhesion.
How do you distinguish sickle cell anemia from sickle cell trait on hemoglobin electrophoresis? Sickle cell anemia (HbSS): HbS >HbA (no HbA present) | Sickle cell trait (HbAS): HbA >HbS (HbA ~60%, HbS ~40%). In trait, HbA exceeds HbS — key distinguishing point. Both have normal MCV (unlike thalassemia).
What is HbSC disease and why is it clinically important? Compound heterozygote — one HbS gene + one HbC gene (Glu→Lys at β6). Milder hemolysis than HbSS but HIGHER risk of retinopathy and avascular necrosis. Spleen may persist longer (less autosplenectomy). HbC causes target cells and mild hemolysis due to crystal formation.
SickleCellAnemia_anki.txtDo the same for thalassemia. 20 very high yield, NEET PG 2026 cards, Anki cards, covering nearly 100% of topics, and be smart.
thalassemia pathology alpha beta globin chain imbalance ineffective erythropoiesis hemolysis
beta thalassemia major minor intermedia genetics mutations HbA2 HbF electrophoresis diagnosis
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Thalassemia
What is the fundamental defect in thalassemia and how does it differ between alpha and beta thalassemia? Thalassemia = quantitative defect in globin chain synthesis (unlike sickle cell = qualitative). Beta thalassemia: reduced/absent beta-globin chain synthesis → excess alpha chains. Alpha thalassemia: reduced/absent alpha-globin chain synthesis → excess beta chains (form HbH = β4) or gamma chains (form Hb Barts = γ4).
What is the molecular basis of beta thalassemia and its two subtypes? Beta thalassemia caused by POINT MUTATIONS (>200 known) on chromosome 11 affecting transcription, splicing, or translation of beta-globin gene. β0 mutation: NO beta-chain production. β+ mutation: REDUCED beta-chain production. (Contrast with alpha thalassemia — caused by DELETIONS.)
What is the molecular basis of alpha thalassemia and its gene locus? Alpha thalassemia caused by DELETIONS of alpha-globin genes on chromosome 16. Normal individuals have 4 alpha-globin genes (2 per chromosome: αα/αα). Deletion of 1, 2, 3, or all 4 genes produces increasingly severe disease.
What are the four clinical syndromes of alpha thalassemia based on number of gene deletions? 1 gene deleted (-α/αα): Silent carrier — normal, no anemia | 2 genes deleted (--/αα or -α/-α): Alpha thalassemia trait — mild microcytic anemia | 3 genes deleted (--/-α): HbH disease — moderate hemolytic anemia, HbH (β4 tetramers) | 4 genes deleted (--/--): Hb Barts hydrops fetalis — incompatible with life, stillborn, Hb Barts (γ4)
What is the primary mechanism of anemia in beta thalassemia major? Excess unpaired alpha chains precipitate within erythroblasts → membrane damage → INEFFECTIVE ERYTHROPOIESIS (intramedullary destruction of erythroid precursors) — this is the PREDOMINANT cause. Secondary: peripheral hemolysis of those RBCs that do enter circulation. (Harrison's, p. 2927)
What is ineffective erythropoiesis and what is its M:E ratio? Destruction of erythroid precursors WITHIN the bone marrow before they mature into RBCs. M:E ratio <1:1 (erythroid hyperplasia). RPI is LOW despite erythroid hyperplasia — distinguishes it from hemolytic anemia where RPI >2.5. Seen in: beta thalassemia major, megaloblastic anemia, sideroblastic anemia, MDS.
What are the skeletal complications of beta thalassemia major and their pathological basis? Severe anemia → intense erythropoietic drive → marrow expansion → cortical bone thinning and remodeling. Skull X-ray: CREW-CUT / HAIR-ON-END appearance. Facial bones: CHIPMUNK FACIES (frontal bossing, maxillary hypertrophy, depression of nasal bridge). Also: pathological fractures, osteoporosis.
What is the hemoglobin electrophoresis pattern in beta thalassemia major (β0/β0)? HbA: ABSENT (0%) | HbF: markedly elevated (>90%) — compensatory | HbA2: elevated (3.5–7%) | This pattern = no HbA, predominantly HbF. In β+/β+: small amount of HbA present.
What is the hemoglobin electrophoresis pattern in beta thalassemia minor (trait)? HbA: present (normal ~95–97%) | HbA2: ELEVATED >3.5% (KEY diagnostic finding — most important) | HbF: mildly elevated (1–5%) | MCV: low (<70 fL) | MCH: low. Elevated HbA2 is the hallmark of beta thalassemia trait.
How do you distinguish beta thalassemia trait from iron deficiency anemia — both cause microcytic hypochromic anemia? Beta thal trait: HbA2 >3.5%, normal/high RBC count, normal serum iron/ferritin, low MCV but RBC COUNT NORMAL OR HIGH (Mentzer index <13) | Iron deficiency: HbA2 normal/low, low RBC count, low serum iron + ferritin, high RDW, Mentzer index >13. Note: iron deficiency can MASK elevated HbA2 — treat iron first then recheck.
What is the Mentzer Index and how is it used? Mentzer Index = MCV ÷ RBC count. <13 → suggests Thalassemia trait (many small RBCs) | >13 → suggests Iron deficiency anemia (fewer, small RBCs). Simple bedside screening tool — NOT diagnostic alone.
What is the peripheral smear in beta thalassemia major? Microcytic hypochromic RBCs, target cells (codocytes — MOST characteristic), tear drop cells (dacrocytes), nucleated RBCs, basophilic stippling (aggregated ribosomes/RNA), Howell-Jolly bodies (hyposplenism), marked anisocytosis and poikilocytosis, polychromatophilia.
What causes iron overload in thalassemia major and what organs are affected? Two causes: 1. Repeated blood transfusions (each unit = 200–250 mg iron, no excretion pathway) 2. Increased GI iron absorption due to ineffective erythropoiesis (↑ erythropoietic drive suppresses hepcidin → ↑ ferroportin activity → ↑ iron absorption). Organs: heart (cardiomyopathy — most common cause of death), liver (cirrhosis), endocrine glands (diabetes, hypogonadism, hypothyroidism, hypoparathyroidism — bronze diabetes).
What is the pathological basis of splenomegaly in thalassemia major? 1. Extramedullary hematopoiesis (marrow expansion → spleen, liver become sites of blood production) 2. Sequestration and destruction of abnormal RBCs. Massive splenomegaly → hypersplenism → worsens pancytopenia → increased transfusion requirement.
What are HbH and Hb Barts — composition, and clinical significance? HbH = β4 tetramers — forms when only 1 alpha gene remains (3-gene deletion). Unstable, precipitates → hemolytic anemia, splenomegaly. Hb Barts = γ4 tetramers — forms when ALL 4 alpha genes deleted. Has very high O2 affinity (useless for O2 delivery) → severe tissue hypoxia → hydrops fetalis → stillbirth or death shortly after birth.
What is the normal composition of hemoglobin in adults and at what age does the HbF→HbA switch occur? HbA (α2β2): ~97% | HbA2 (α2δ2): ~2.5% | HbF (α2γ2): <1%. HbF→HbA switch occurs at 6 months of age (gamma→beta switch). This is why beta thalassemia major presents at 6 months–2 years (when HbF declines and HbS/HbA production becomes critical).
Why does beta thalassemia major present at 6 months of age and not at birth? At birth, HbF (α2γ2) predominates — no need for beta chains. At 6 months, gamma-to-beta switch occurs. In beta thalassemia major, no/little beta chain production → HbA cannot form → severe anemia manifests only after HbF declines.
What is the difference between beta thalassemia major, intermedia, and minor? Major (β0/β0 or β0/β+): transfusion-dependent, severe anemia from 6 months | Intermedia (β+/β+ or β0/β+): moderate anemia, transfusion-independent or occasional transfusions, presents later | Minor/Trait (β0/normal or β+/normal): asymptomatic carrier, elevated HbA2, mild microcytosis, NO significant anemia
What is the treatment of beta thalassemia major and the role of chelation therapy? Regular blood transfusions (target HbA >9–10 g/dL) + iron chelation therapy (Desferrioxamine IV/SC, Deferasirox oral, Deferiprone oral) to prevent iron overload. Splenectomy if hypersplenism. Curative: allogeneic hematopoietic stem cell transplantation (HSCT). New: gene therapy (Betibeglogene — approved).
What is the diagnostic approach to thalassemia in order of tests? Step 1: CBC — microcytic hypochromic anemia, low MCV, high RBC count (thal trait) | Step 2: Peripheral smear — target cells, basophilic stippling | Step 3: Serum iron + ferritin — normal (excludes IDA) | Step 4: Hb electrophoresis / HPLC — elevated HbA2 (>3.5%) confirms beta thal trait; HbF elevation in major | Step 5: Molecular/genetic testing — identifies specific mutation for genetic counseling
Thalassemia_anki.txtDo the same for hereditary spherocytosis.
hereditary spherocytosis pathology spectrin ankyrin band 3 protein deficiency membrane defect
hereditary spherocytosis osmotic fragility splenectomy diagnosis clinical features complications
#separator:tab
#html:false
#notetype:Basic
#deck:NEET PG 2026::Hereditary Spherocytosis
What is the fundamental defect in hereditary spherocytosis (HS)? Deficiency of RBC membrane cytoskeletal proteins → loss of vertical linkage between lipid bilayer and cytoskeleton → membrane lipid blebs off → RBC loses surface area but retains volume → spherical shape → reduced deformability → trapped and destroyed in spleen
What proteins are deficient in hereditary spherocytosis and which is most common? Ankyrin (most common, ~50%) → also spectrin (alpha and beta), Band 3 protein, Protein 4.2. These proteins form the vertical links between the lipid bilayer and the spectrin cytoskeleton. All are encoded by different genes → HS is genetically heterogeneous.
What is the inheritance pattern of hereditary spherocytosis? Predominantly AUTOSOMAL DOMINANT (~75%). Autosomal recessive (~25%) — typically more severe, involves spectrin or protein 4.2 defects. Sporadic mutations also occur (~25% of AD cases have no family history). Most common hereditary hemolytic anemia in people of Northern European ancestry (prevalence 1:2000–1:5000).
What is the pathological mechanism by which spherocytes are destroyed in HS? Spherocytes are rigid (low surface area:volume ratio) → cannot deform to pass through narrow splenic sinusoids → sequestered in splenic cords → exposed to hypoxic, acidic, glucose-depleted environment → further membrane damage → phagocytosed by splenic macrophages. Hemolysis is EXTRAVASCULAR, predominantly in SPLEEN.
What is the peripheral smear finding in hereditary spherocytosis? Spherocytes — small, round, densely staining RBCs with NO central pallor (central pallor occupies >1/3 of normal RBC diameter). Also: polychromatophilia (reticulocytosis), anisocytosis. ABSENCE of target cells (unlike thalassemia). Spherocytes are seen in both HS and AIHA.
How do you distinguish Hereditary Spherocytosis from AIHA — both show spherocytes? HS: DAT NEGATIVE, family history positive, lifelong anemia, normal MCV or slightly low | AIHA: DAT POSITIVE, acquired, associated with SLE/CLL/drugs. OSMOTIC FRAGILITY increased in BOTH. DAT is the single most important distinguishing test.
What is the osmotic fragility test — principle, finding in HS, and limitation? RBCs placed in decreasing concentrations of saline (hypotonic solutions). Normal RBCs swell before lysing. Spherocytes (reduced surface area:volume) lyse at HIGHER saline concentration (earlier) → INCREASED osmotic fragility. Limitation: may be normal in mild HS — INCUBATED osmotic fragility test (incubate blood at 37°C for 24h before testing) is more sensitive.
What is the EMA (Eosin-5-Maleimide) binding test and why is it preferred over osmotic fragility? EMA binds to Band 3 protein and Rh-related proteins on RBC surface. In HS, Band 3 and associated proteins are reduced → DECREASED EMA fluorescence by flow cytometry. More sensitive and specific than osmotic fragility. Preferred first-line test for HS diagnosis in modern practice. Also detects protein 4.2 deficiency.
What is the gold standard diagnostic test for hereditary spherocytosis? Historically: osmotic fragility test (incubated). Currently: EMA binding test (flow cytometry) — more sensitive, specific, and reproducible. Genetic/molecular testing identifies specific mutation. Diagnosis can also be made clinically: spherocytes on smear + family history + negative DAT + splenomegaly.
What are the classic clinical features of hereditary spherocytosis? Triad: Anemia (hemolytic, variable severity) + Jaundice (unconjugated hyperbilirubinemia) + Splenomegaly. Jaundice may be intermittent (worsens with infections). Gallstones (pigment stones — calcium bilirubinate) in ~50% by adulthood due to chronic hemolysis. Aplastic crisis possible.
What causes aplastic crisis in hereditary spherocytosis and what is the organism responsible? Parvovirus B19 infects erythroid precursors (via P antigen receptor) → transient cessation of erythropoiesis → sudden severe anemia (reticulocytopenia). Dangerous in HS because baseline RBC survival is already short (~20 days vs normal 120 days). Treat with RBC transfusion and supportive care.
What type of gallstones form in hereditary spherocytosis and why? Pigment gallstones (calcium bilirubinate stones) — black pigment stones. Caused by chronic hemolysis → excess unconjugated bilirubin → excreted as bile pigment → precipitates in gallbladder. Seen in ~50% of adults with HS. Indication for cholecystectomy at time of splenectomy.
What are the lab findings in hereditary spherocytosis? ↑ Unconjugated bilirubin, ↑ LDH, ↓ haptoglobin (extravascular hemolysis — mild decrease), ↑ reticulocyte count (compensatory), MCHC ELEVATED (>36 g/dL — most specific lab finding in HS, due to cellular dehydration), MCV normal or slightly low, DAT negative.
Why is MCHC elevated in hereditary spherocytosis? Membrane loss → RBC loses surface area → water redistributes → cell dehydrates → hemoglobin concentration per cell increases → MCHC elevated (>36 g/dL). MCHC elevation is the most specific routine CBC finding in HS. Used as a screening indicator.
What is the role of splenectomy in hereditary spherocytosis? Splenectomy removes the site of destruction → eliminates hemolysis → corrects anemia. Spherocytes PERSIST on smear post-splenectomy (membrane defect remains) but are no longer destroyed. Indicated in: moderate-severe HS, growth retardation, recurrent aplastic crises, symptomatic gallstones. Deferred until age >5–6 years (infection risk). Post-splenectomy: Howell-Jolly bodies appear on smear.
What vaccines are mandatory before splenectomy in hereditary spherocytosis? Pneumococcal vaccine (Streptococcus pneumoniae), Haemophilus influenzae type b (Hib) vaccine, Meningococcal vaccine. Given at least 2 weeks before elective splenectomy. Post-splenectomy prophylactic penicillin also recommended (especially in children <5 years).
What are the post-splenectomy blood smear changes in hereditary spherocytosis? Howell-Jolly bodies (nuclear remnants — normally removed by spleen), target cells, acanthocytes, thrombocytosis (transient post-splenectomy platelet surge → thrombosis risk), persistence of spherocytes. Reticulocyte count normalizes.
What is the severity classification of hereditary spherocytosis? Mild (~20–30%): Hb >11 g/dL, retic 3–8%, MCHC mildly elevated, compensated hemolysis | Moderate (~60–65%): Hb 8–11 g/dL, retic 8–12% | Severe (~5%): Hb <8 g/dL, retic >10%, transfusion-dependent, usually autosomal recessive (spectrin deficiency)
What is the pathological basis of indirect hyperbilirubinemia and pigment gallstone formation in chronic hemolysis (HS)? Hemolysis → excess RBC breakdown → heme → biliverdin → unconjugated bilirubin (UCB). UCB is lipid soluble, transported bound to albumin, NOT water soluble → cannot be excreted in urine (acholuric jaundice). Liver conjugates UCB → excreted in bile → excess bile pigment → calcium bilirubinate precipitation → BLACK PIGMENT STONES.
How does HS differ from Hereditary Elliptocytosis (HE)? HS: spectrin/ankyrin/Band 3 defect → vertical linkage failure → spherocytes, increased osmotic fragility | HE: spectrin dimer-dimer self-association defect → HORIZONTAL linkage failure → elliptocytes/ovalocytes on smear, usually mild hemolysis. Both: AD inheritance, extravascular hemolysis, DAT negative. HE smear shows >25% elliptocytes.
HereditarySpherocytosis_anki.txt